Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Apr;59(4):610–612. doi: 10.1038/bjc.1989.123

'Debulking' surgery is unnecessary in advanced abdominal Burkitt lymphoma in Iraq.

A al-Attar 1, A Attra 1, R al-Bagdadi 1, M al-Naimi 1, T al-Saleem 1, J Pritchard 1
PMCID: PMC2247130  PMID: 2713246

Abstract

In a previous study (Burkitt lymphoma study I, BL I) between 1982 and 1984, we used a multidrug rotating chemotherapy schedule, now known as 'GRAB', to treat 24 Iraqi children with non-localised BL (Murphy stages II, III and IV). At the time of reporting, actuarial survival was 50% (current actual survival 42%) and the major morbidity and mortality was not from resistant or relapsed lymphoma, but from complications of the tumour lysis syndrome, sepsis and early abdominal surgery. The study (BL II) reported here was carried out between 1984 and 1986; we used GRAB to treat 24 newly and consecutively diagnosed children with advanced Burkitt lymphoma but discouraged early 'debulking' surgery and paid special attention to supportive care during the first two weeks of treatment. As in BL I, no radiotherapy was used. Twenty patients (83.8%) attained complete remission: 17 (71%), including three of the seven stage IV patients, survive continuously disease-free at a median of 26 months (range 18-36 months) from diagnosis. We have previously pointed out that GRAB, without radiotherapy, may be especially suited for use in some developing countries. From this study we conclude that, with appropriate supportive care and minimal surgery, survival rates over 50% may be achieved. Our next studies are aimed at defining a 'good risk' group of patients, who may be curable without alkylating agents and a 'poor risk' group, who need more intensive therapy.

Full text

PDF
610

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Attar A., Al-Mondhiry H., Al-Bahrani Z., Al-Saleem T. Burkitt's lymphoma in Iraq. Clinical and pathological study of forty-seven patients. Int J Cancer. 1979 Jan 15;23(1):14–17. doi: 10.1002/ijc.2910230104. [DOI] [PubMed] [Google Scholar]
  2. Al-Attar A., Pritchard J., Al-Saleem T., Al-Naimi M., Alash N., Attra A. Intensive chemotherapy for non-localised Burkitt's lymphoma. Arch Dis Child. 1986 Oct;61(10):1013–1019. doi: 10.1136/adc.61.10.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson J. R., Wilson J. F., Jenkin D. T., Meadows A. T., Kersey J., Chilcote R. R., Coccia P., Exelby P., Kushner J., Siegel S. Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med. 1983 Mar 10;308(10):559–565. doi: 10.1056/NEJM198303103081003. [DOI] [PubMed] [Google Scholar]
  4. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  5. Magrath I. T., Janus C., Edwards B. K., Spiegel R., Jaffe E. S., Berard C. W., Miliauskas J., Morris K., Barnwell R. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood. 1984 May;63(5):1102–1111. [PubMed] [Google Scholar]
  6. Murphy S. B., Bowman W. P., Abromowitch M., Mirro J., Ochs J., Rivera G., Pui C. H., Fairclough D., Berard C. W. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986 Dec;4(12):1732–1739. doi: 10.1200/JCO.1986.4.12.1732. [DOI] [PubMed] [Google Scholar]
  7. Murphy S. B. Childhood non-Hodgkin's lymphoma. N Engl J Med. 1978 Dec 28;299(26):1446–1448. doi: 10.1056/NEJM197812282992606. [DOI] [PubMed] [Google Scholar]
  8. Patte C., Philip T., Rodary C., Bernard A., Zucker J. M., Bernard J. L., Robert A., Rialland X., Benz-Lemoine E., Demeocq F. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol. 1986 Aug;4(8):1219–1226. doi: 10.1200/JCO.1986.4.8.1219. [DOI] [PubMed] [Google Scholar]
  9. Philip T., Biron P., Maraninchi D., Gastaut J. A., Hervé P., Flesh Y., Goldstone A. H., Souhami R. L. Role of massive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's malignant lymphoma. Lancet. 1984 Feb 18;1(8373):391–391. doi: 10.1016/s0140-6736(84)90437-9. [DOI] [PubMed] [Google Scholar]
  10. Tucker M. A., D'Angio G. J., Boice J. D., Jr, Strong L. C., Li F. P., Stovall M., Stone B. J., Green D. M., Lombardi F., Newton W. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987 Sep 3;317(10):588–593. doi: 10.1056/NEJM198709033171002. [DOI] [PubMed] [Google Scholar]
  11. Ziegler J. L. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N Engl J Med. 1977 Jul 14;297(2):75–80. doi: 10.1056/NEJM197707142970202. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES